Article
Evidence for type replacement as a consequence of vaccination and implications for cervical screening.
Journal of the National Cancer Institute. Monographs - 1 Aug 2026
Gray Penelope, Louvanto Karolina
Abstract excerpt
The success of prophylactic human papillomavirus (HPV) vaccination in reducing disease burden came with an epidemiological concern: HPV type replacement, the potential compensatory increase of nonvaccine targeted HPV types following the elimination of HPV16 and 18. Postvaccination surveillance across several countries suggests some signs of increase in the nonvaccine targeted HPV types, which may be explainable...
Read the complete abstract on PubMedTopics
- Humans
- Papillomavirus Infections
- Papillomavirus Vaccines
- Uterine Cervical Neoplasms
- Female
- Vaccination
